Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Differential regulation of A2A adenosine receptor expression in human epithelial cells by IL-1b and TNF-a — Silvana Morello (2005) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Differential regulation of A2A adenosine receptor expression in human epithelial cells by IL-1b and TNF-a
Shared by
Peter J Barnes
Imperial College London
Differential regulation of A2A adenosine receptor expression in human epithelial cells by IL-1b and TNF-a
Article
2005
en
Authors
+2 more
SM
Silvana Morello
KI
Kazuhiro Ito
Peter J Barnes
Imperial College London
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2006
IL-1β and TNF-α Regulation of the Adenosine Receptor (A2A) Expression: Differential Requirement for NF-κB Binding to the Proximal Promoter
Silvana Morello
,
Kazuhiro Ito
,
Satoshi Yamamura
,
Kang‐Yun Lee
,
Elen Jazrawi
,
Patricia deSouza
,
Peter J Barnes
,
Carla Cicala
,
Ian M. Adcock
Article
2004
Differential expression of IL‐10 receptor by epithelial cells and alveolar macrophages
Sai Kiang Lim
,
Gaetano Caramori
,
Katsuyuki Tomita
,
Elen Jazrawi
,
Thomas Oates
,
Kian Fan Chung
,
Peter J Barnes
,
Ian M. Adcock
Article
2013
Human Monocytes Receptors Inhibits IL-12 Production by Ligand-Activation of the Adenosine A2a
Ronald L. Wilder
,
Ilia J. Elenkov
,
Lisa McGuire
,
Marianna Crane
,
George Chrousos
,
Amrey A. Link
,
Tomoshige Kino
,
James A. Worth
Article
2000
Ligand-Activation of the Adenosine A2a Receptors Inhibits IL-12 Production by Human Monocytes
Amrey A. Link
,
Tomoshige Kino
,
James A. Worth
,
Jennifer L. McGuire
,
Marianna Crane
,
George Chrousos
,
Ronald L. Wilder
,
Ilia J. Elenkov
Article
1993
Expression of interleukin‐1 receptor antagonist (IL‐1ra) by human circulating polymorphonuclear cells
Fabio Re
,
Manuela Mengozzi
,
Marta Muzio
,
Charles A. Dinarello
,
Alberto Mantovani
,
Francesco Colotta
Discussion(0)
No comments yet. Be the first to comment.